Significant shareholders:
| Shareholder/Beneficial Owner | Shares | % ISC |
|---|---|---|
| Lombard Odier Investment Managers | 143,680,429 | 14.79 |
| Canaccord Genuity Wealth Management | 92,591,748 | 9.53 |
| T Rowe Price Global Investments | 77,842,802 | 8.02 |
| Artisan Partners | 74,179,949 | 7.64 |
| Hargreaves Lansdown, stockbrokers | 71,476,572 | 7.36 |
| Mr Richard Griffiths | 60,891,441 | 6.27 |
| Interactive Investor | 59,085,719 | 6.08 |
| Dr Andrew Nelson* | 38,835,514 | 4.00 |
| M&G Investments | 38,159,663 | 3.93 |
as at 30 April 2025
Quoted: AIM (London Stock Exchange)
Other Exchanges / Trading Platforms: The Company is not listed on any other exchanges or trading platforms.
Number of securities in issue: 971,198,059 Ordinary shares.
Shares not in public hands: Insofar as the Company is aware, the percentage of securities that is not in public hands is 15.0%, these being held by directors, their families and significant shareholders.
Own shares held in treasury: The Company holds 4,115 Ordinary Shares in treasury.
Details on any restrictions on the transfer of securities: There are no restrictions on the transfer of securities.
Applicable code(s): The Company is subject to the UK City Code on Takeovers and Mergers. The Code is administered by The Panel and Takeovers in Mergers.
* Per the Company’s RNS announcement of 11 May 2020, 12,121,711 Ordinary Shares of Dr Nelson’s total beneficial interest are subject to a Sale and Repurchase Agreement with Equities First Holdings.